Previous Blogs

last year, an expert from CFDA Jinan Quality Inspection Center for Pharmaceutical Packaging Materials spoke about preparation of a guidance for stability studies.

By Lynn Yao

January 26, 2018

In 2016, the China Federal Drug Administration (CFDA) made two announcements regarding packaging of parenteral drug products. Per these announcements, stability studies of packaging materials should refer to protection, compatibility, safety and functionality properties.